Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national
3
×
national blog main
national top stories
new york blog main
abbvie
amgen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
industry
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adverse events database
allergan
amunix pharmaceuticals
anifrolumab
antitrust
apremilast
astrazeneca
autoimmune disease
azitra
belantamab mafodotin
What
monday
3
×
abbvie’s
adults
allergan
anathema
approved
awaited
barbecuing
bio
camping
cardiologist
center
check
cholesterol
class
conference
day
democrat
details
drug
elements
fda
flop
hit
house
j
j’s
labor
leaked
long
look
lower
medicines
migraine
new
night
nod
opioid
paris
pill
Language
unset
Current search:
monday
×
national
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More